<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d452" origId="Disopyramide"><sentence id="DrugDDI.d452.s0" origId="s0" text="If phenytoin or other hepatic enzyme inducers are taken concurrently with Norpace or Norpace CR, lower plasma levels of disopyramide may occur."><entity id="DrugDDI.d452.s0.e0" origId="s0.p0" charOffset="3-12" type="drug" text="phenytoin"/><entity id="DrugDDI.d452.s0.e1" origId="s0.p6" charOffset="74-81" type="drug" text="Norpace"/><entity id="DrugDDI.d452.s0.e2" origId="s0.p8" charOffset="85-95" type="drug" text="Norpace CR"/><entity id="DrugDDI.d452.s0.e3" origId="s0.p11" charOffset="120-132" type="drug" text="disopyramide"/><pair id="DrugDDI.d452.s0.p0" e1="DrugDDI.d452.s0.e0" e2="DrugDDI.d452.s0.e1" interaction="true"/><pair id="DrugDDI.d452.s0.p1" e1="DrugDDI.d452.s0.e0" e2="DrugDDI.d452.s0.e2" interaction="true"/><pair id="DrugDDI.d452.s0.p2" e1="DrugDDI.d452.s0.e0" e2="DrugDDI.d452.s0.e3" interaction="false"/><pair id="DrugDDI.d452.s0.p3" e1="DrugDDI.d452.s0.e1" e2="DrugDDI.d452.s0.e2" interaction="false"/><pair id="DrugDDI.d452.s0.p4" e1="DrugDDI.d452.s0.e1" e2="DrugDDI.d452.s0.e3" interaction="false"/><pair id="DrugDDI.d452.s0.p5" e1="DrugDDI.d452.s0.e2" e2="DrugDDI.d452.s0.e3" interaction="false"/></sentence><sentence id="DrugDDI.d452.s1" origId="s1" text="Monitoring of disopyramide plasma levels is recommended in such concurrent use to avoid ineffective therapy."><entity id="DrugDDI.d452.s1.e0" origId="s1.p15" charOffset="14-26" type="drug" text="disopyramide"/></sentence><sentence id="DrugDDI.d452.s2" origId="s2" text="Other antiarrhythmic drugs (eg, quinidine, procainamide, lidocaine, propranolol) have occasionally been used concurrently with Norpace."><entity id="DrugDDI.d452.s2.e0" origId="s2.p21" charOffset="6-26" type="drug" text="antiarrhythmic drugs"/><entity id="DrugDDI.d452.s2.e1" origId="s2.p24" charOffset="32-41" type="drug" text="quinidine"/><entity id="DrugDDI.d452.s2.e2" origId="s2.p25" charOffset="43-55" type="drug" text="procainamide"/><entity id="DrugDDI.d452.s2.e3" origId="s2.p26" charOffset="57-66" type="drug" text="lidocaine"/><entity id="DrugDDI.d452.s2.e4" origId="s2.p27" charOffset="68-79" type="drug" text="propranolol"/><entity id="DrugDDI.d452.s2.e5" origId="s2.p34" charOffset="127-134" type="drug" text="Norpace"/><pair id="DrugDDI.d452.s2.p0" e1="DrugDDI.d452.s2.e0" e2="DrugDDI.d452.s2.e1" interaction="false"/><pair id="DrugDDI.d452.s2.p1" e1="DrugDDI.d452.s2.e0" e2="DrugDDI.d452.s2.e2" interaction="false"/><pair id="DrugDDI.d452.s2.p2" e1="DrugDDI.d452.s2.e0" e2="DrugDDI.d452.s2.e3" interaction="false"/><pair id="DrugDDI.d452.s2.p3" e1="DrugDDI.d452.s2.e0" e2="DrugDDI.d452.s2.e4" interaction="false"/><pair id="DrugDDI.d452.s2.p4" e1="DrugDDI.d452.s2.e0" e2="DrugDDI.d452.s2.e5" interaction="false"/><pair id="DrugDDI.d452.s2.p5" e1="DrugDDI.d452.s2.e1" e2="DrugDDI.d452.s2.e2" interaction="false"/><pair id="DrugDDI.d452.s2.p6" e1="DrugDDI.d452.s2.e1" e2="DrugDDI.d452.s2.e3" interaction="false"/><pair id="DrugDDI.d452.s2.p7" e1="DrugDDI.d452.s2.e1" e2="DrugDDI.d452.s2.e4" interaction="false"/><pair id="DrugDDI.d452.s2.p8" e1="DrugDDI.d452.s2.e1" e2="DrugDDI.d452.s2.e5" interaction="false"/><pair id="DrugDDI.d452.s2.p9" e1="DrugDDI.d452.s2.e2" e2="DrugDDI.d452.s2.e3" interaction="false"/><pair id="DrugDDI.d452.s2.p10" e1="DrugDDI.d452.s2.e2" e2="DrugDDI.d452.s2.e4" interaction="false"/><pair id="DrugDDI.d452.s2.p11" e1="DrugDDI.d452.s2.e2" e2="DrugDDI.d452.s2.e5" interaction="false"/><pair id="DrugDDI.d452.s2.p12" e1="DrugDDI.d452.s2.e3" e2="DrugDDI.d452.s2.e4" interaction="false"/><pair id="DrugDDI.d452.s2.p13" e1="DrugDDI.d452.s2.e3" e2="DrugDDI.d452.s2.e5" interaction="false"/><pair id="DrugDDI.d452.s2.p14" e1="DrugDDI.d452.s2.e4" e2="DrugDDI.d452.s2.e5" interaction="false"/></sentence><sentence id="DrugDDI.d452.s3" origId="s3" text="Excessive widening of the QRS complex and/or prolongation of the Q-T interval may occur in these situations."/><sentence id="DrugDDI.d452.s4" origId="s4" text="In healthy subjects, no significant drug-drug interaction was observed when Norpace was coadministered with either propranolol or diazepam."><entity id="DrugDDI.d452.s4.e0" origId="s4.p48" charOffset="76-83" type="drug" text="Norpace"/><entity id="DrugDDI.d452.s4.e1" origId="s4.p53" charOffset="115-126" type="drug" text="propranolol"/><entity id="DrugDDI.d452.s4.e2" origId="s4.p55" charOffset="130-138" type="drug" text="diazepam"/><pair id="DrugDDI.d452.s4.p0" e1="DrugDDI.d452.s4.e0" e2="DrugDDI.d452.s4.e1" interaction="false"/><pair id="DrugDDI.d452.s4.p1" e1="DrugDDI.d452.s4.e0" e2="DrugDDI.d452.s4.e2" interaction="false"/><pair id="DrugDDI.d452.s4.p2" e1="DrugDDI.d452.s4.e1" e2="DrugDDI.d452.s4.e2" interaction="false"/></sentence><sentence id="DrugDDI.d452.s5" origId="s5" text="Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels."><entity id="DrugDDI.d452.s5.e0" origId="s5.p57" charOffset="30-37" type="drug" text="Norpace"/><entity id="DrugDDI.d452.s5.e1" origId="s5.p59" charOffset="42-51" type="drug" text="quinidine"/><entity id="DrugDDI.d452.s5.e2" origId="s5.p62" charOffset="91-103" type="drug" text="disopyramide"/><entity id="DrugDDI.d452.s5.e3" origId="s5.p65" charOffset="142-151" type="drug" text="quinidine"/><pair id="DrugDDI.d452.s5.p0" e1="DrugDDI.d452.s5.e0" e2="DrugDDI.d452.s5.e1" interaction="true"/><pair id="DrugDDI.d452.s5.p1" e1="DrugDDI.d452.s5.e0" e2="DrugDDI.d452.s5.e2" interaction="false"/><pair id="DrugDDI.d452.s5.p2" e1="DrugDDI.d452.s5.e0" e2="DrugDDI.d452.s5.e3" interaction="false"/><pair id="DrugDDI.d452.s5.p3" e1="DrugDDI.d452.s5.e1" e2="DrugDDI.d452.s5.e2" interaction="false"/><pair id="DrugDDI.d452.s5.p4" e1="DrugDDI.d452.s5.e1" e2="DrugDDI.d452.s5.e3" interaction="false"/><pair id="DrugDDI.d452.s5.p5" e1="DrugDDI.d452.s5.e2" e2="DrugDDI.d452.s5.e3" interaction="false"/></sentence><sentence id="DrugDDI.d452.s6" origId="s6" text="Norpace does not increase serum digoxin levels."><entity id="DrugDDI.d452.s6.e0" origId="s6.p66" charOffset="0-7" type="drug" text="Norpace"/></sentence><sentence id="DrugDDI.d452.s7" origId="s7" text="Patients taking disopyramide phosphate and erythromycin concomitantly may develop increased serum concentrations of disopyramide resulting in excessive widening of the QRS complex and/or prolongation of the Q-T interval."><entity id="DrugDDI.d452.s7.e0" origId="s7.p73" charOffset="16-38" type="drug" text="disopyramide phosphate"/><entity id="DrugDDI.d452.s7.e1" origId="s7.p75" charOffset="43-55" type="drug" text="erythromycin"/><entity id="DrugDDI.d452.s7.e2" origId="s7.p79" charOffset="116-128" type="drug" text="disopyramide"/><pair id="DrugDDI.d452.s7.p0" e1="DrugDDI.d452.s7.e0" e2="DrugDDI.d452.s7.e1" interaction="true"/><pair id="DrugDDI.d452.s7.p1" e1="DrugDDI.d452.s7.e0" e2="DrugDDI.d452.s7.e2" interaction="false"/><pair id="DrugDDI.d452.s7.p2" e1="DrugDDI.d452.s7.e1" e2="DrugDDI.d452.s7.e2" interaction="false"/></sentence><sentence id="DrugDDI.d452.s8" origId="s8" text="Patients taking disopyramide phosphate and hepatic enzyme inhibitors concomitantly should be closely monitored."><entity id="DrugDDI.d452.s8.e0" origId="s8.p88" charOffset="16-38" type="drug" text="disopyramide phosphate"/><entity id="DrugDDI.d452.s8.e1" origId="s8.p90" charOffset="51-68" type="drug" text="enzyme inhibitors"/><pair id="DrugDDI.d452.s8.p0" e1="DrugDDI.d452.s8.e0" e2="DrugDDI.d452.s8.e1" interaction="true"/></sentence><sentence id="DrugDDI.d452.s9" origId="s9" text="Until data on possible interactions between verapamil and disopyramide phosphate are obtained, disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration."><entity id="DrugDDI.d452.s9.e0" origId="s9.p97" charOffset="44-53" type="drug" text="verapamil"/><entity id="DrugDDI.d452.s9.e1" origId="s9.p99" charOffset="58-80" type="drug" text="disopyramide phosphate"/><entity id="DrugDDI.d452.s9.e2" origId="s9.p103" charOffset="95-107" type="drug" text="disopyramide"/><entity id="DrugDDI.d452.s9.e3" origId="s9.p112" charOffset="176-185" type="drug" text="verapamil"/><pair id="DrugDDI.d452.s9.p0" e1="DrugDDI.d452.s9.e0" e2="DrugDDI.d452.s9.e1" interaction="false"/><pair id="DrugDDI.d452.s9.p1" e1="DrugDDI.d452.s9.e0" e2="DrugDDI.d452.s9.e2" interaction="false"/><pair id="DrugDDI.d452.s9.p2" e1="DrugDDI.d452.s9.e0" e2="DrugDDI.d452.s9.e3" interaction="false"/><pair id="DrugDDI.d452.s9.p3" e1="DrugDDI.d452.s9.e1" e2="DrugDDI.d452.s9.e2" interaction="false"/><pair id="DrugDDI.d452.s9.p4" e1="DrugDDI.d452.s9.e1" e2="DrugDDI.d452.s9.e3" interaction="false"/><pair id="DrugDDI.d452.s9.p5" e1="DrugDDI.d452.s9.e2" e2="DrugDDI.d452.s9.e3" interaction="true"/></sentence></document>